294 related articles for article (PubMed ID: 23284171)
1. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.
Varghese BV; Koohestani F; McWilliams M; Colvin A; Gunewardena S; Kinsey WH; Nowak RA; Nothnick WB; Chennathukuzhi VM
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2187-92. PubMed ID: 23284171
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
3. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
[TBL] [Abstract][Full Text] [Related]
4. No REST for fibroids.
Rueda BR; Davis JS
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):1980-1. PubMed ID: 23355686
[No Abstract] [Full Text] [Related]
5. Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells.
Al-Hendy A; Diamond MP; Boyer TG; Halder SK
J Clin Endocrinol Metab; 2016 Apr; 101(4):1542-51. PubMed ID: 26820714
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
Crabtree JS; Jelinsky SA; Harris HA; Choe SE; Cotreau MM; Kimberland ML; Wilson E; Saraf KA; Liu W; McCampbell AS; Dave B; Broaddus RR; Brown EL; Kao W; Skotnicki JS; Abou-Gharbia M; Winneker RC; Walker CL
Cancer Res; 2009 Aug; 69(15):6171-8. PubMed ID: 19622772
[TBL] [Abstract][Full Text] [Related]
7. Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis.
Cloud AS; Koohestani F; McWilliams MM; Ganeshkumar S; Gunewardena S; Graham A; Nothnick WB; Chennathukuzhi VM
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2205524119. PubMed ID: 36282915
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.
Yu L; Saile K; Swartz CD; He H; Zheng X; Kissling GE; Di X; Lucas S; Robboy SJ; Dixon D
Mol Med; 2008; 14(5-6):264-75. PubMed ID: 18231572
[TBL] [Abstract][Full Text] [Related]
9. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract][Full Text] [Related]
10. PLIN2 Functions As a Novel Link Between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells.
Okeigwe I; Bulun S; Liu S; Rademaker AW; Coon JS; Kujawa S; Robins J; Yin P
J Clin Endocrinol Metab; 2019 Dec; 104(12):6256-6264. PubMed ID: 31504629
[TBL] [Abstract][Full Text] [Related]
11. The Epidemiology and Genetics of Uterine Leiomyoma.
Styer AK; Rueda BR
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():3-12. PubMed ID: 26725703
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.
Borahay MA; Asoglu MR; Mas A; Adam S; Kilic GS; Al-Hendy A
Reprod Sci; 2017 Sep; 24(9):1235-1244. PubMed ID: 27872195
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of tuberin in human uterine leiomyoma.
Cui L; Ren Y; Yin H; Wang Y; Li D; Liu M; Zhu Y; Lin W; Tang XD; Gui Y; Zheng XL
Fertil Steril; 2011 Apr; 95(5):1805-8. PubMed ID: 21145542
[TBL] [Abstract][Full Text] [Related]
14. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.
Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157
[TBL] [Abstract][Full Text] [Related]
15. A nongenomic mechanism for "metalloestrogenic" effects of cadmium in human uterine leiomyoma cells through G protein-coupled estrogen receptor.
Liu J; Yu L; Castro L; Yan Y; Sifre MI; Bortner CD; Dixon D
Arch Toxicol; 2019 Oct; 93(10):2773-2785. PubMed ID: 31468104
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect.
Bernacchioni C; Ciarmela P; Vannuzzi V; Greco S; Vannuccini S; Malentacchi F; Pellegrino P; Capezzuoli T; Sorbi F; Cencetti F; Bruni P; Donati C; Petraglia F
Fertil Steril; 2021 Jun; 115(6):1576-1585. PubMed ID: 33500141
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle.
Tian R; Wang Z; Shi Z; Li D; Wang Y; Zhu Y; Lin W; Gui Y; Zheng XL
Fertil Steril; 2013 Jan; 99(1):256-263.e3. PubMed ID: 23043685
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.
Navarro A; Yin P; Monsivais D; Lin SM; Du P; Wei JJ; Bulun SE
PLoS One; 2012; 7(3):e33284. PubMed ID: 22428009
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium.
Zaitseva M; Vollenhoven BJ; Rogers PA
Mol Hum Reprod; 2007 Aug; 13(8):577-85. PubMed ID: 17553814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
